BiliaryTractCancer near Englewood, NJ

Care Philosophy: "Better people means better experiences. Our care team is committed to delivering results that change lives."

Biography: Dr. Ran Reshef trained in Hematology, Oncology, and Bone Marrow Transplantation and received a Master of Science degree in Translational Research from the University of Pennsylvania. He joined Columbia University in 2015 as Director of Translational Research for the Blood and Marrow Transplantation program. He is the Clinical Lead for the CAR-T Cell Program at Columbia, a principal investigator at the Columbia Center for Translational Immunology, and a member of the Herbert Irving Comprehensive Cancer Center.

Biography: Margaret T Lee, MD cares for children with blood disorders, such as anemias (sickle cell anemia, thalassemia, and iron deficiency), bleeding (including idiopathic thrombocytopenic purpura [ITP], hemophilia, and von Willebrand disease), and clotting disorders (such as deep vein thrombosis). Dr. Lee's area of interest is a rare group of diseases called vascular anomalies. There is relatively little known about these disorders, and the care of patients with vascular anomalies requires a multidisciplinary group of physicians from several specialties (dermatology, surgery, cardiology, neurology, and hematology/oncology)-all of whom are available at NewYork-Presbyterian/Morgan Stanley Children's Hospital. Hematologists play a role in the medical treatment of vascular tumors and the supportive care of clotting and bleeding complications that are associated with some types of vascular malformations. Dr. Lee is an active participant in the Vascular Anomalies Group at NYP/Morgan Stanley Children's Hospital, as well as the Vascular Anomalies Special Interest Group of the American Society of Pediatric Hematology/Oncology, which is looking at novel therapies for vascular anomalies and their complications.

Biography: Prakash Satwani, MD specializes in the use of bone marrow transplantation to treat children and adolescents with leukemia, lymphoma, or hemophagocytic lymphohistiocytosis. Bone marrow transplantation is a dynamic, intriguing field with multiple complex issues. Dr. Satwani has always enjoyed solving puzzles and is attracted to the intellectual challenge of caring for patients whose lives may be saved or extended with bone marrow transplantation. Dr. Satwani is also inspired and motivated by the long-lasting and rich relationships formed with patients and their families, and often keeps in touch with families long after their child's treatment has been completed. Dr. Satwani teaches medical students, residents, fellows, nurses, and nurse practitioners about bone marrow transplantation. It's important to educate people so they can learn the latest advances and provide the best care possible for patients. To continue to achieve those advances, Dr. Satwani conducts clinical research in reducing the life-threatening complications related to transplantation, such as infections and graft-versus-host disease. Dr. Satwani and colleagues also evaluate reduced-intensity bone marrow transplantation preparative regimens, which use lower doses of chemotherapy with the hope of decreasing short-term and long-term complications without compromising the effectiveness of treatment.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Biography: Dr. Joseph Jurcic is a Professor of Medicine at Columbia University Medical Center and the Director of the Hematologic Malignancies Section within the Division of Hematology/Oncology. He specializes in Medical Oncology and focuses on leukemia, myelodysplastic syndromes, and myeloproliferative disorders. Based in New York, NY, Dr. Jurcic is affiliated with NewYork-Presbyterian/Columbia University Irving Medical Center. He received his M.D. from the Perelman School of Medicine at the University of Pennsylvania and completed his training at Barnes-Jewish Hospital and Memorial Sloan Kettering Cancer Center. He is board-certified in both Medical Oncology and Hematology.Dr. Jurcic's clinical expertise includes the treatment of acute and chronic leukemias, myeloproliferative neoplasms, and myelodysplastic syndromes. His research interests encompass acute myeloid leukemia, radioimmunotherapy with alpha and beta particle-emitting radioisotopes, monoclonal antibody therapy, developing novel small molecule inhibitors, and molecular monitoring of minimal residual disease. Recognized as one of New York Magazine's "Best Doctors" from 2014 to 2024, he has authored or co-authored over 80 articles and book chapters. He has served as the principal investigator on more than 25 clinical trials. Additionally, Dr. Jurcic lectures at national and international conferences and is the Leukemia Section Editor for The Oncologist.

Biography: Rajshekhar Chakraborty, MD is an assistant professor of medicine at Columbia University Irving Medical Center in the division of hematology/oncology. After receiving his medical degree from University of Delhi, India, he completed his residency in internal medicine at Icahn School of Medicine at Mount Sinai-Queens Hospital Center. Subsequently, he spent three years as a clinical researcher in plasma cell disorders at the Mayo Clinic, Rochester, followed by fellowship in hematology/oncology at the Cleveland Clinic. During fellowship, he conducted outcomes research with a focus on quality of life and treatment-related toxicities in plasma cell disorders. After fellowship, he started his job as Assistant Professor of Medicine at the Multiple Myeloma and Amyloidosis Program at Columbia University Irving Medical Center. Dr. Chakraborty cares primarily for patients with plasma cells disorders, including multiple myeloma, amyloidosis, MGUS, POEMS syndrome, and Waldenstrom's macroglobulinemia. His research interests include clinical trials and outcomes research in plasma cell disorders.

Biography: Dr. Yoanna Pumpalova is an Assistant Professor of Medicine and medical oncologist at Columbia University Irving Medical Center where she specializes in the treatment of gastrointestinal malignancies, with a focus on colorectal and anal cancers. She received her MD from Weill Cornell Medical College and completed internship and residency training in Internal Medicine and Global Health at Stanford University. She then completed fellowship training in Medical Oncology at Columbia University/New York Presbyterian Hospital. Dr. Pumpalova works as part of a multidisciplinary team with the mission of delivering compassionate and state-of-the-art oncologic care to each patient, using a precision medicine approach to provide innovative and promising treatments. Dr. Pumpalova is actively involved in translational research to understand the biological mechanisms driving early onset colorectal cancer. She collaborates with Dr. Joel Gabre, a gastroenterologist and clinician scientist and Dr. Beatrice Dionigi, colorectal surgeon, on research to understand how early onset colorectal cancer differs from average onset colorectal cancer, with the goal of uncovering novel ways to treat all patients with colorectal cancer. Dr. Pumpalova is also the site principal investigator of industry-sponsored clinical trials investigating novel therapies for the treatment of colorectal cancer. Further, Dr. Pumpalova conducts studies in low- and middle-income countries focused on early detection and screening for colorectal cancer. She has active studies in South Africa and Dominican Republic. Her research goal is to improve outcomes for patients diagnosed with colorectal cancer, regardless of where they reside. Her work has been recognized by several awards including an ASCO Young Investigator Award and ASCO Career Development Award. In the NewsColumbia Researchers Seek Answers for Rise of Colon Cancer in Younger PatientsWhat to Know About the Rise of Colorectal Cancer in Younger PeopleExploring Strategies for Earlier Colon Cancer Detection in Sub-Saharan Africa

Biography: Dr. Usama Ahmed Ali is a colorectal surgeon who has expertise in the whole gamut of colorectal surgery, including minimally invasive and open colorectal surgical procedures, anorectal operations, and colonoscopy. He completed his medical training at Utrecht University in the Netherlands in 2007. He then did colorectal research as a PhD researcher and was a colorectal research fellow at the Cleveland Clinic in 2011 under the guidance of Dr. Pokala Ravi Kiran. He trained in general and colorectal surgery at the University Medical Center Utrecht and the St. Antonius Hospital in The Netherlands after which he worked as a general and colorectal surgeon in Riverieland Ziekenhuis in Tiel until 2022. Dr. Ahmed Ali has an interest in a wide spectrum of colorectal conditions including benign colorectal conditions, diverticular disease, colon and rectal cancer, inflammatory bowel disease, polyposis and anorectal disorders such as hemorrhoids, abscesses and anal fistulas. Dr. Ahmed Ali trained extensively with Dr. Kiran and Dr. James Church. He works collaboratively with Dr. Church on complex fistula disease within the Anal Fistula Center and is part of the Hereditary Cancer and Familial Polyposis Center. He also works closely with Dr. Kiran in the management of various conditions including complex and reoperative colorectal surgery. Dr. Ahmed Ali has a double PhD in medicine, one of which is in the surgical treatment of inflammatory bowel disease. He also has a Masters in Evidence-Based Medicine from Oxford University. He is a Member of Dutch Society for Surgery and Dutch Society for Gastro-intestinal Surgery (2021).

Biography: Dr. Llore is an Assistant Professor of Surgery at Columbia University and an Attending Transplant Surgeon at New York Presbyterian Hospital. Dr. Llore received her undergraduate degree from Fordham University and her medical degree from New York University School of Medicine. She completed general surgery residency at Georgetown University Hospital and abdominal transplant/hepatobiliary fellowship training at New York Presbyterian Columbia and Weill Cornell. She received additional training on the immune response after a liver transplant and xenotransplantation with Dr. Megan Sykes at Columbia Center for Translational Immunology (CCTI). She is board-certified in general surgery and received specialty training in abdominal transplant and hepatobiliary surgery. Her practice interests focus on the surgical management of children and adults with liver and bile duct disease, including benign and malignant liver tumors. She practices minimally invasive surgical techniques in liver surgery to shorten recovery times and reduce post operative discomfort. Dr. Llore is interested in surgical education and is the Associate Program Director for the ASTS certified surgical fellowship program.

Biography: Lisa A. Kachnic, MD, one of the nation's leading radiation oncologists and a pioneer of new approaches to optimize the effectiveness of radiation therapy, is the Chu H. Chang Professor and Chief of the Department of Radiation Oncology at Columbia University Vagelos College of Physicians and Surgeons (VP&S) and Chief of the Radiation Oncology Service at NewYork-Presbyterian/Columbia University Irving Medical Center (CUIMC). She also serves as Associate Director of Radiation Oncology and Science in the Herbert Irving Comprehensive Cancer Center (HICCC). Dr. Kachnic's combined focus on clinical excellence, technological innovation, and patient-centered research continues to advance the field of radiation oncology, which has resulted in over 150 publications and over $17 million in research support from major federal and non-profit agencies. She is widely recognized for gastrointestinal research that has transformed the standard of care for several cancers by integrating novel radiation delivery techniques. A past president of the American Board of Radiology, Dr. Kachnic is internationally known for her clinical trial leadership positions in the National Cancer Institute and its cooperative group research bases. She currently serves as Vice Chair of the Radiation Oncology Committee and Co-Chair of the Ano-Rectal Subcommittee for the SWOG Cancer Research Network research base, for which she is the multi-modality executive officer, as well as NRG Oncology's Associate PI of their NCORP (NCI Community Oncology Research Program) and chair of the NCORP's Cancer Control Committee. At Columbia, she is contact PI of Columbia's NCORP and is co-PI of several NCI training grants for residents and early career faculty.

Biography: Israel Deutsch, M.D., is Assistant Professor of Radiation Oncology at New York-Presbyterian/Columbia University Medical Center. Dr. Deutsch cares for patients with all types of cancer, with a special interest in Prostate, Gynecologic, and Head & Neck cancers. He is Director of Brachytherapy Services in the Department of Radiation Oncology. Dr. Deutsch is a respected researcher with numerous peer-reviewed contributions to medical literature and has edited many book chapters in his areas of expertise. He is a member of the Review Committee on Continuing Medical Education at Columbia University Medical Center. Dr. Deutsch received his medical degree from Albert Einstein College of Medicine. He then received transitional year training during an internship at New York Hospital Queens, after which he completed his radiation oncology residency at SUNY Downstate Medical Center. Dr. Deutsch then furthered his training with a fellowship in brachytherapy at Memorial Sloan-Kettering Cancer Center. In collaboration with several clinical and basic science colleagues, he is conducting a number of clinical and translational studies. Dr. Deutsch sits on the Internal Review Board (IRB) for Clinical Trials and is also a member of the Children's Oncology Group (COG) as Investigator representing the Department of Radiation Oncology. Dr. Deutsch is very involved in residency education and serves as Associate Director of the Radiation Oncology Residency Program at New York Presbyterian/Columbia University Medical Center.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Biography: Dr. Karie Runcie, MD is a Hematology Specialist who practices in New York, NY. She is 37 years old and has been practicing for 12 years. Dr. Karie Runcie, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center.